Eye abnormalities linked to metal deficiencies in children with thalassemia receiving frequent transfusions

Jaipur: A study by doctors at the govt-run JK Lon Hospital has found that nearly 43% of children with thalassemia who undergo ...

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
TipRanks on MSN

Bristol-Myers Squibb’s Luspatercept Study: A Potential Game-Changer for Alpha-Thalassemia

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...
Everyday Health on MSN

New Blood Test to Rule Out Alzheimer’s Gets FDA Clearance

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...
BMJ

Association between frequency of meeting daily step thresholds and all-cause mortality and cardiovascular disease in older women

Objective To examine the associations between the number of days per week achieving various daily step thresholds and all-cause mortality and cardiovascular disease (CVD) incidence in older women.

Vertex Pharmaceuticals Incorporated: Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK at the North American Cystic Fibrosis Conference

Data presented on outcomes following treatment with CFTR modulators add to growing body of evidence that reduced level of sweat chloride is associated with improved clinical outcomes, particularly ...